Mondelez International, Inc. (MDLZ) › Analysis

Mondelez International, Inc. (MDLZ) analysis, February 13, 2026

Published February 13, 2026 · MDLZ chart, levels and live analysis

Key Updates

Mondelez shares advanced 2.06% to $62.45 since the February 10 report, extending the post-earnings recovery rally and pushing YTD gains to an impressive 16.01%. The advance occurred despite limited new fundamental catalysts, with only four news items during the period. Key developments include continued analyst support from Morningstar reiterating the stock's 18% discount to fair value, emerging clarity on cocoa price benefits delayed until 2027, and competitive pressure from Ferrero's $3.1 billion Kellogg acquisition positioning it as the third-largest sweet packaged foods maker globally. The stock demonstrates resilience above $62 despite persistent headwinds from elevated cocoa costs and weak U.S. consumer demand.

Current Trend

MDLZ has delivered exceptional YTD performance of 16.01%, significantly outpacing broader consumer staples benchmarks. The stock has advanced 9.12% over the past month and 4.05% over five days, establishing a clear uptrend with support at the $59-60 level tested during the post-earnings selloff. Current price of $62.45 represents a new recovery high, with the stock trading at 17 times 2026 earnings according to Morningstar analysis. The 6-month performance of just 0.42% indicates the recent rally represents a material shift in sentiment, likely driven by valuation compression during mid-2025 followed by recognition of the company's emerging market exposure and eventual cocoa cost relief. Technical momentum remains positive with consistent higher lows since early February.

Investment Thesis

The investment thesis centers on Mondelez's differentiated emerging market exposure (40% of sales versus 25-30% for peers) providing superior growth potential, combined with eventual margin recovery as cocoa costs normalize in 2027. The company maintains a wide economic moat through cost advantages and intangible assets, with 70% of snack offerings holding or gaining market share. Analysts project 3.8% compound annual revenue growth through 2029 and 10% earnings growth from 2026-2029, supported by mid-single-digit growth in emerging markets. The 3.3% dividend yield provides downside protection while the company navigates near-term margin pressure. At 18% below fair value per Morningstar's assessment, the stock offers compelling risk-reward despite conservative 2026 guidance of flat-to-2% organic revenue growth and flat-to-5% earnings growth.

Thesis Status

The investment thesis remains intact and is strengthening as the stock price approaches fair value while fundamental positioning improves. The 16.01% YTD gain has narrowed the valuation discount from 25% in mid-January to 18% currently, yet the stock remains attractively valued given projected 10% earnings growth through 2029. Near-term challenges are well-understood and priced in: management confirmed 2027 will be the first year to benefit from lower cocoa prices, providing clear visibility on margin recovery timing. The competitive landscape has intensified with Ferrero's Kellogg acquisition creating a stronger third-place competitor, though this validates the attractive economics of branded food categories. Consumer weakness remains a headwind, but the company's innovation pipeline (Marvel OREO collaboration, sugar-free variants, premium offerings) demonstrates proactive adaptation. The thesis of patient capital benefiting from emerging market leverage and eventual margin expansion remains compelling.

Key Drivers

Cocoa cost dynamics continue to dominate the narrative, with prices declining nearly 30% in the past month after peaking at $10,000 per metric ton in May. However, manufacturers purchased cocoa at near-record prices and hedged months in advance, meaning Mondelez cannot reduce consumer prices immediately despite spot market deflation. Management explicitly stated 2027 will be the first year to benefit from lower cocoa prices, providing clear timeline for margin recovery. Consumer demand weakness persists, with shoppers prioritizing essential foods over discretionary snacks and basket growth remaining stagnant. The company is responding through expanded distribution in value and club stores, varied price points, and accelerated premium/healthier product rollouts. Competitive intensity has increased with Ferrero's $3.1 billion Kellogg acquisition strengthening its U.S. position, though Ferrero's revenue of approximately $23.6 billion still trails Mondelez's $36.4 billion scale. Innovation continues with the Marvel OREO collaboration featuring color-changing creme technology, demonstrating brand vitality and consumer engagement capabilities.

Technical Analysis

MDLZ has established a clear uptrend since early February, with the $59-60 zone providing solid support during the post-earnings selloff. The stock advanced 2.06% to $62.45 in the current period, marking a new recovery high and confirming bullish momentum. The 16.01% YTD gain significantly outpaces the 0.42% six-month return, indicating a material sentiment shift in recent months. Key resistance lies at the $63-64 level, while support has strengthened at $61. The five-day gain of 4.05% and one-month advance of 9.12% demonstrate accelerating positive momentum. Volume patterns suggest institutional accumulation, consistent with Morningstar's recommendation and the stock's 5-star rating. The technical setup favors continued upside toward fair value in the $72-75 range, representing 15-20% potential appreciation from current levels. Short-term consolidation near $62 would be healthy before the next leg higher.

Bull Case

Bear Case

Get a message when the MDLZ picture changes — the agent team watches the levels and the news for you.Create a free account

More MDLZ analyses